This inventor holds 6 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Holy Stone Healthcare Co., Ltd., Aihol Corporation. Active years: 2017-2025.
Company Filing History:
Years Active: 2017-2025
Title: Innovations of Inventor Hua-Yang Lin
Introduction
Hua-Yang Lin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug conjugates. With a total of 6 patents to his name, Lin's work focuses on innovative treatments for various cancers.
Latest Patents
Among his latest patents, Lin has developed a conjugate of an active drug and a glycosaminoglycan, such as hyaluronic acid (HA). This conjugate is particularly useful in the treatment of certain cancers, with active drugs including lenalidomide, nimesulide, and gemcitabine. Another notable patent involves hyaluronic acid-nimesulide conjugates that contain one or two disaccharide units, showcasing his innovative approach to drug formulation.
Career Highlights
Throughout his career, Hua-Yang Lin has worked with several notable companies, including Holy Stone Healthcare Co., Ltd. and Aihol Corporation. His experience in these organizations has allowed him to advance his research and contribute to the development of effective cancer treatments.
Collaborations
Due to space constraints, the details of his collaborations will not be included.
Conclusion
Hua-Yang Lin's innovative work in drug conjugates highlights his commitment to advancing cancer treatment. His contributions continue to impact the pharmaceutical industry positively.